This is a summary of the European public assessment report (EPAR) for Cyanokit. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Cyanokit.
Therapeutic Indication
### Therapeutic indication Treatment of known or suspected cyanide poisoning. Cyanokit is to be administered together with appropriate decontamination and supportive measures.
Therapeutic Area (MeSH)
ATC Code
V03AB33
ATC Item
hydroxocobalamin
Pharmacotherapeutic Group
All other therapeutic products
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| hydroxocobalamin | N/A | 羟钴胺 |
EMA Name
Cyanokit
Medicine Name
Cyanokit
Aliases
N/ANo risk management plan link.
